IDO1 has been implicated in mediating immunosuppression in cancer, and high expression of IDO1 in CRC cells can counteract T cell invasion through tryptophan depletion and production of proapoptotic tryptophan catabolites (47, 48). This evidence concerns the gene IDO1 and colorectal carcinoma.